Karen L. Smith Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Karen L. Smith.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Karen L. Smith. Karen L. Smith is a Director in ANTARES PHARMA, INC. ($ATRS) and a Director in SANGAMO THERAPEUTICS, INC ($SGMO) and a EVP, R&D and CMO in Jazz Pharmaceuticals plc ($JAZZ) and a Global Head of R&D and CMO in Jazz Pharmaceuticals plc ($JAZZ) and a Director in ACCELERON PHARMA INC ($XLRN) and a Director in Sucampo Pharmaceuticals, Inc. ($SCMP) and a EVP, Chief Medical Officer in Emergent BioSolutions Inc. ($EBS).
Address: CONNAUGHT HOUSE, 1 BURLINGTON RD, FL. 4 DUBLIN 4 Ireland
Companies in which Karen L. Smith is an Insider
ACCELERON PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Karen L. Smith: Director
Holdings: 9,561 shares
Current Value: $226,978
Latest Transaction: Apr 05 2021
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ANTARES PHARMA, INC.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Karen L. Smith: Director
Holdings: 54,193 shares
Current Value: $119,225
Latest Transaction: Jun 15 2020
$ATRS Market Capitalization: $356.70M
$ATRS Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Emergent BioSolutions Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen L. Smith: EVP, Chief Medical Officer
Holdings: 9,252 shares
Current Value: $271,546
Latest Transaction: Feb 26 2021
$EBS Market Capitalization: $1.21B
$EBS Previous Close: $29.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Jazz Pharmaceuticals plc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen L. Smith: EVP, R&D and CMO, Global Head of R&D and CMO
Holdings: 28,474 shares
Current Value: $3,560,674
Latest Transaction: Mar 07 2018
$JAZZ Market Capitalization: $7.62B
$JAZZ Previous Close: $125.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SANGAMO THERAPEUTICS, INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Karen L. Smith: Director
Holdings: 25,700 shares
Current Value: $98,945
Latest Transaction: Mar 01 2021
$SGMO Market Capitalization: $254.24M
$SGMO Previous Close: $3.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sucampo Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karen L. Smith: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 13 2018
$SCMP Market Capitalization: $496.69M
$SCMP Previous Close: $11.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Karen L. Smith
Sentiment: All, XLRN, ATRS, EBS, JAZZ, SGMO, SCMP
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Smith Karen L. | Director | Option Exercise | M | 52.99 | 2,050 | 108,630 | 4,085 | |
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Smith Karen L. | Director | Option Exercise | M | 41.64 | 1,875 | 78,075 | 3,750 | |
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Smith Karen L. | Director | Option Exercise | M | 35.34 | 5,000 | 176,700 | 10,000 | |
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Smith Karen L. | Director | Sell | S | 141.15 | 641 | 90,477 | 1,622 | 2.3 K to 1.6 K (-28.33 %) |
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Smith Karen L. | Director | Sell | S | 140.13 | 11,223 | 1,572,679 | 2,263 | 13.5 K to 2.3 K (-83.22 %) |
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Smith Karen L. | Director | Buy | M | 52.99 | 2,050 | 108,630 | 13,486 | 11.4 K to 13.5 K (+17.93 %) |
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Smith Karen L. | Director | Buy | M | 41.64 | 1,875 | 78,075 | 11,436 | 9.6 K to 11.4 K (+19.61 %) |